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Justyna Kalinowska-Tłusćik,§ Shabnam Shaabani,† and Alexander Dömling*,†
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ABSTRACT: An Ugi multicomponent reaction based two-
step strategy was applied to generate medium-sized rings. In
the ﬁrst linear expansion phase, a series of diamines reacted
with cyclic anhydrides to produce diﬀerent lengths of terminal
synthetic amino acids as the starting material for the second
phase. The Ugi-4-center 3-component reaction was utilized to
construct complex medium-sized rings (8−11) by the addition
of isocyanides and oxo components. This method features
mild conditions and a broad substrate scope.
Medium-sized rings are molecules which contain between8 and 11 ring atoms.1,2 Surprisingly, they are highly
underrepresented in screening libraries and in general in the
synthetic organic chemistry world. Examples of bioactive
medium-sized cycles, however, exist and include taxol (8-
membered), griseoviridin (9-membered),3 crotalanian alkaloids
(10-membered), and diplodialide natural products (11-
membered).4 As opposed to small rings or macrocycles,
medium-sized rings are a challenging class of synthetic targets.5
While small rings can often be closed based on favorable
enthalpy, macrocyclic ring closure needs a favorable entropic
component. Medium cycles, however, often show an
unfavorable entropy and enthalpy component, including Pitzer
ring strains and transannular interactions, for their ring closure
and thus are highly demanding synthetic targets.6 Diﬀerent
synthetic methodologies have been applied for the ring closure
of medium-sized cycles, including ring-closing metathesis
(RCM), macro-lactonization, metal mediated C−C coupling
reactions, and ring expansion.7 However, these methods mostly
suﬀer from low yields and limited substrate scope. Therefore,
the discovery of general methodologies for the fast and eﬃcient
construction of various medium rings in good yields and with
useful levels of diversity is of considerable importance. Our
design toward the synthesis of complex medium ring structures
is based on two simple but diverse reactions steps. Moreover, it
is based on commercially available starting materials. The ﬁrst
step involves a ring opening reaction of cyclic carboxylic acid
anhydrides with unprotected diamines to aﬀord α,ω-amino
acids. In the next step, α,ω-amino acids are used in an Ugi
reaction with oxo components and isocyanides to close
medium rings of 8−11 membered size (Figure 1). This method
closely follows our recently described strategy to create a
manifold of artiﬁcial macrocycles by a short sequence involving
an initial linear diversiﬁcation, followed by an exponential
diversiﬁcation step of macrocyclization using an Ugi and
Passerini multicomponent reaction (MCR) .8,9
We initially started our study by the synthesis of α-amino ω-
carboxylic acid by reacting symmetrical and unsymmetrical
cyclic anhydride with diamines followed by an Ugi reaction. We
reacted a total of nine cyclic anhydrides with ﬁve diamines
providing 11 amino acids of diﬀerent linker length (Scheme 1).
For the synthesis of medium-sized ring compounds, we
focused on the small diamines, such as ethylene diamine,
propane diamine, butane diamine, and pentane diamine
derivatives (Scheme 1). The ring opening reaction of cyclic
anhydrides was carried out by slowly dropping anhydride to the
unprotected alkyl diamine solution in THF as an aprotic polar
solvent. This reaction proceeded under diluted conditions (0.1
M), on a 10 mmol scale, at room temperature, and the product
α-amino ω-carboxylic acid was isolated in good yields (59−
80%). Next, the macrocyclic ring closure was performed by Ugi
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Figure 1. Described macrocyclization strategy.
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MCR under optimized conditions using 1 equiv of oxo
component and isocyanide (Scheme 1). We extensively
screened diﬀerent conditions by varying temperature, solvent,
and time. By using methanol as a solvent at 0.01 M
concentrations of reactants and after 48 h at room temperature,
a range of medium-sized rings were obtained in optimal yields.
To investigate substrate scope and limitations, we synthesized
23 examples, as shown in Scheme 2. Several commercially
available aliphatic, aromatic, and heteroaromatic aldehyde and
ketone building blocks reacted as oxo-components in the Ugi
reaction to aﬀord the medium-sized cycles in acceptable good
to excellent (21−65%) yields after puriﬁcation by column
chromatography. Variously functionalized isocyanides, such as
aliphatic, aromatic, and benzylic, including indole-derived
isocyanides, reacted well to give the desired products.
In light of our eﬀorts to ﬁnd an eﬀective method of
synthesizing medium-sized rings in a one-pot reaction,
including amino acid synthesis and also in situ isocyanide
synthesis, we used some unpuriﬁed synthetic amino acids in the
ring closure step by simply removing the THF solvent from the
anhydride ring opening reaction and reacting the crude amino
acid with the oxo and isocyanide components in methanol.
With this one-pot procedure, we were able to produce medium-
sized rings (for examples, 6a, 6b, 6h, 6k, and 6u) in 27% to
65% yields. In a similar way, we also simpliﬁed and extensively
studied the in situ isocyanide formation and ring closure
reactions in one pot. Thus, we used our recently described in
situ isocyanide synthesis protocol from formamides to produce
the complex IMCR products in one pot, without tedious
synthesis and isolation of the foul smelling and toxic
isocyanides.10 Triphosgene (0.4 equiv) with Et3N (2.4 equiv)
in dichloromethane (DCM) (0.5 M) proved to be the best
dehydrating system for the isocyanide formation. N-Benzylfor-
mamide was treated with 2.4 equiv of Et3N and 0.4 equiv of
triphosgene in DCM (0.5 M) as solvent at 0 °C. After 15 min,
the crude mixture was passed through a small bed of silica gel
into a round-bottom ﬂask, which already contained amino acid
3i and 2-azidobenzaldehyde, as shown in Scheme 3. The
reaction mixture was stirred for another 48 h, and the 11-
membered medium-sized ring product (6p) was obtained in
31% yield after column puriﬁcation. These in situ methods will
increase the value of MCR chemistry, even though the in situ
isocyanide process gives a lower yield compared to the
procedure involving isolation and puriﬁcation of the isocyanide
and amino acid (6p, 40% yield, Scheme 3).
A determinant of passive membrane permeation is the
potential of macro- and medium-sized cycles to form
intramolecular hydrogen bonds which improve their chame-
leonic behavior by switching between conformations in
aqueous solution and while passing through lipid cell
membranes by exposing polar atoms and hydrophobic residues,
respectively.11 Thus, we were interested in oxidizing the sulfur
medium-sized cycle 6q to the sulfoxide and the sulfone,
respectively. The chemistry to the sulfoxide and sulfones was
accomplished by m-chloroperbenzoic acid (mCPBA) in DCM
(Scheme 4). The compound 6q was reacted with 1.0 and 4.0
equiv of mCPBA in DCM for 4 h to aﬀord sulfoxide 7qa and
Scheme 1. Starting Materials for the Synthesis of α-Amino
ω-Carboxylic Acidsa
aAll starting materials are commercially available.
Scheme 2. Ugi-4CR Synthesis of Medium-Sized Rings and
the Product Structures with Isolated Yields
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sulfone 7qb in excellent yields (70% and 90%, respectively).
Our future plan is to investigate how this sulfoxide and sulfone
can participate in the formation of amide−sulfoxide and
amide−sulfone intramolecular hydrogen bonds and thus
determine the 3D conformations.
Diastereomer formation was also investigated by reacting 3j,
chlorobenzaldehyde, and benzyl isocyanide. Not surprisingly, a
moderate dr of 7:3 was observed by 1H NMR of the crude
reaction mixture (Scheme 5).
In order to conﬁrm the product structure and to gain insight
into the ring conformation and intra- vs intermolecular
hydrogen bonding, we crystallized compound 6i and
determined its solid-state structure by X-ray crystallography
(Figure 2). Interestingly, in the 6i structure, the exocyclic
isocyanide derived amide group is bending back over the
macrocycle to form an intramolecular hydrogen bonding with
the medium-sized cycle amide group. Moreover, the medium
cycle secondary amide undergoes a hydrogen bonding with the
same amide group of a neighboring medium cycle. This kind of
intramolecular hydrogen bonding in related medium or
macrocyclic systems has been determined to facilitate passive
membrane diﬀusion, an important determinant of cellular
activity and oral bioavailability.12,13
Physicochemical properties are of uttermost importance for
the usefulness of compounds as chemical probes or develop-
ment candidates. What is the proﬁle of our medium-sized
cycles? To answer this question, we constructed a random
virtual 1000 medium ring library (Supporting Information).
Then, we calculated the properties of the library, including
molecular weight, lipophilicity, number of hydrogen bond
donors and acceptors, number of rotatable bonds, polar surface
area, and moment of inertia. Interestingly, an analysis of the
library shows 30% obey the Lipinski rule of ﬁve (RO5). Even
more stringent central nervous system multiparameter
optimization (CNS MPO) desirability can be reached for a
percentage of the compound.14 The cLogP versus MW
distribution is favorably drug-like with an average MW and
cLogP of 538 and 3.3, respectively (Figure 3). Moreover,
punctual analysis of 3D modeled representatives and X-ray
structures underline the nonﬂat shapes of the medium-sized
rings.
In conclusion, we introduced a very mild, straightforward
two-step, rapid, and highly diverse medium-sized cycle (8−11
membered) synthesis pathway via MCRs. The strategy using an
Ugi reaction in the cyclization is particularly appealing for
several reasons. First, it oﬀers outstanding diversity. Second, it
potentially provides various medicinally and pharmaceutically
important products containing an amide bond that can serve as
conformationally constrained peptidomimetics. Finally, this
strategy will allow a unique route for the synthesis of medium-
sized cyclic nonpeptidic molecules. We are currently synthesiz-
Scheme 3. One-Pot in Situ Isocyanide Synthesis Followed by
Ugi-MCR
Scheme 4. Selective Oxidative Modiﬁcations on Refractory
Sulfur Contained Medium Cycles
Scheme 5. Example of Reaction Diasteroselectivity
Figure 2. Representative MCR-derived 10-membered ring 6i in solid
state featuring intramolecular and intermolecular hydrogen bonding
contacts.
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ing and screening extensive medium-ring libraries and will
report on their biological activity in due course.
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Figure 3. Some calculated physicochemical properties of the chemical
space of medium-sized rings. (A) cLogP over MW scatter plot. (B)
Oral CNS scoring radar plot. (C) Compound distribution based on
oral CNS scoring.14
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